Antihemophilic factor is a concentrate containing factor VIII — a clotting factor that is used for treatment of persons with hemophilia. Hemophilia is a genetic disorder characterized by the deficiency or absence of one of the proteins (or factors) in blood plasma that is responsible for clotting. Low levels of one of these plasma proteins result in bleeding and difficulty clotting in the affected individual. A doctor or healthcare provider prescribes antihemophilic therapies.
Please note: Country-specific regulatory requirements limit the information we can provide about our products. In addition, approved indications (uses), product labels, and packaging for a prescription drug may differ between countries. Please refer to the prescribing information provided for your country of residence.
Koāte®-DVI, Antihemophilic Factor (Human) reaches patients around the world.
|
